Mark N. Brook

5.2k total citations
14 papers, 385 citations indexed

About

Mark N. Brook is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark N. Brook has authored 14 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark N. Brook's work include Prostate Cancer Treatment and Research (5 papers), Genetic Associations and Epidemiology (4 papers) and Global Cancer Incidence and Screening (3 papers). Mark N. Brook is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Genetic Associations and Epidemiology (4 papers) and Global Cancer Incidence and Screening (3 papers). Mark N. Brook collaborates with scholars based in United Kingdom, United States and Australia. Mark N. Brook's co-authors include Montserrat García‐Closas, Michael E. Jones, Anthony J. Swerdlow, Penny Coulson, Nilanjan Chatterjee, Parichoy Pal Choudhury, Minouk J. Schoemaker, Nick Orr, Koveela Govindasami and Zsofia Kote‐Jarai and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Mark N. Brook

14 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark N. Brook United Kingdom 11 155 148 119 111 69 14 385
Kathie Sun United States 5 54 0.3× 108 0.7× 94 0.8× 129 1.2× 60 0.9× 5 291
Kathryn E. Hatchell United States 10 207 1.3× 124 0.8× 59 0.5× 47 0.4× 82 1.2× 40 402
Danielle Castillo United States 9 222 1.4× 130 0.9× 81 0.7× 34 0.3× 103 1.5× 27 327
Brigette Tippin Davis United States 9 373 2.4× 184 1.2× 114 1.0× 37 0.3× 126 1.8× 12 543
Elisabetta De Matteis Italy 13 146 0.9× 102 0.7× 138 1.2× 39 0.4× 114 1.7× 33 342
T.S. Sridhar India 14 84 0.5× 150 1.0× 180 1.5× 57 0.5× 158 2.3× 29 421
Gillian M. Belbin United States 13 188 1.2× 142 1.0× 40 0.3× 18 0.2× 49 0.7× 24 442
Karin Elebro Sweden 10 108 0.7× 77 0.5× 147 1.2× 98 0.9× 154 2.2× 17 343
Eleni Kakouri Cyprus 9 132 0.9× 155 1.0× 116 1.0× 28 0.3× 70 1.0× 17 355
Hatef Darabi Sweden 11 171 1.1× 84 0.6× 210 1.8× 82 0.7× 89 1.3× 21 408

Countries citing papers authored by Mark N. Brook

Since Specialization
Citations

This map shows the geographic impact of Mark N. Brook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark N. Brook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark N. Brook more than expected).

Fields of papers citing papers by Mark N. Brook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark N. Brook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark N. Brook. The network helps show where Mark N. Brook may publish in the future.

Co-authorship network of co-authors of Mark N. Brook

This figure shows the co-authorship network connecting the top 25 collaborators of Mark N. Brook. A scholar is included among the top collaborators of Mark N. Brook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark N. Brook. Mark N. Brook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Saunders, Edward J., Tokhir Dadaev, Mark N. Brook, et al.. (2024). Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival. European Urology Oncology. 7(2). 248–257. 3 indexed citations
2.
Eeles, Rosalind A., Elizabeth Bancroft, Edward J. Saunders, et al.. (2024). Effect of polygenic risk score for clinically significant prostate cancer in a screening program: The BARCODE 1 study results.. Journal of Clinical Oncology. 42(16_suppl). 10500–10500. 3 indexed citations
3.
Brook, Mark N., Holly Ní Raghallaigh, Koveela Govindasami, et al.. (2022). Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study. European Urology. 83(3). 257–266. 10 indexed citations
4.
Nyberg, Tommy, Mark N. Brook, Andrew Lee, et al.. (2022). CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer. Journal of Clinical Oncology. 41(5). 1092–1104. 21 indexed citations
5.
6.
Choudhury, Parichoy Pal, Paige Maas, Amber N. Hurson, et al.. (2020). iCARE: An R package to build, validate and apply absolute risk models. PLoS ONE. 15(2). e0228198–e0228198. 39 indexed citations
7.
Choudhury, Parichoy Pal, Amber N. Hurson, Mark N. Brook, et al.. (2019). Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification. JNCI Journal of the National Cancer Institute. 112(3). 278–285. 53 indexed citations
8.
Leongamornlert, Daniel, Edward J. Saunders, Sarah Wakerell, et al.. (2019). Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel. European Urology. 76(3). 329–337. 36 indexed citations
9.
Nyberg, Tommy, Koveela Govindasami, Goska Leslie, et al.. (2018). Homeobox B13 G84E Mutation and Prostate Cancer Risk. European Urology. 75(5). 834–845. 30 indexed citations
10.
Mijušković, Martina, Edward J. Saunders, Daniel Leongamornlert, et al.. (2018). Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease. British Journal of Cancer. 119(1). 96–104. 31 indexed citations
11.
Srinivasan, Srilakshmi, Carson Stephens, Emily Wilson, et al.. (2018). Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function. Clinical Chemistry. 65(1). e1–e9. 18 indexed citations
12.
Eeles, Rosalind A., Daniel Leongamornlert, Edward J. Saunders, et al.. (2018). DNA repair gene panel mutations in young onset prostate cancer cases in the.. Journal of Clinical Oncology. 36(6_suppl). 18–18. 4 indexed citations
13.
Brook, Mark N., Olivia Fletcher, Penny Coulson, et al.. (2015). Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Breast Cancer. Cancer Research. 75(14). 2844–2850. 43 indexed citations
14.
Flanagan, James M., Mark N. Brook, Nick Orr, et al.. (2014). Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study. Cancer Epidemiology Biomarkers & Prevention. 24(1). 221–229. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026